Clinical trials in HIV CNS disease and treatment management.
On May 15 and 16, 2006, the National Institute of Mental Health sponsored a workshop designed to facilitate discussion and collaboration between basic and clinical investigators in neuroAIDS. Day 2 of the meeting featured a series of talks by clinical investigators. Three of these (those by J. McArthur, P. Tebas, and C. Flexner) are described in detail here. The remaining four talks (those by R. Ellis, R. Price, S. Letendre, and R. Robertson) are briefly introduced here, and full-length papers may be found elsewhere in this issue of the Journal.
Ellis
Ronald J
RJ
Department of Neurosciences and HIV Neurobehavioral Research Center, University of California, 150 West Washington St, San Diego, CA 92103, USA. roellis@ucsd.edu
D000818:Animals; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods / Q000639:trends; D020805:Central Nervous System Viral Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics; D002986:Clinical Trials as Topic / Q000379:methods* / Q000639:trends*; D019468:Disease Management; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics; D006801:Humans